The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Medullary renal cell carcinoma (RCC): Genomics and treatment outcomes.
 
Maria Isabel Carlo
No Relationships to Disclose
 
Yingbei Chen
No Relationships to Disclose
 
Joshua Chaim
No Relationships to Disclose
 
Devyn Taylor Coskey
No Relationships to Disclose
 
Kaitlin Woo
No Relationships to Disclose
 
James Hsieh
Honoraria - Chugai Pharma
Consulting or Advisory Role - Chugai Pharma; Eisai; Novartis
Research Funding - CGI; Novartis; Pfizer
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Calithera Biosciences; Exelixis; GlaxoSmithKline; Natera; Novartis
Research Funding - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Novartis; Takeda
 
Darren R. Feldman
Consulting or Advisory Role - Bayer; Gilead Sciences (I); Seagen
Research Funding - Novartis
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Chung-Han Lee
Research Funding - Eisai (Inst); Pfizer (Inst)